A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma

Pleomorphic xanthoastrocytoma (PXA) is a World Health Organization (WHO) Grade II glioma occurring primarily in children and young adults. Most PXAs harbor the known activating mutation BRAF V600E. We report a case of locally recurrent PXA with anaplastic features in a 10-yr-old female. The PXA was...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Susan J., Karajannis, Matthias A., Diolaiti, Daniel, Mansukhani, Mahesh M., Bender, Julia Glade, Kung, Andrew L., Garvin, James H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334470/
https://www.ncbi.nlm.nih.gov/pubmed/28299358
http://dx.doi.org/10.1101/mcs.a001396